Physician profile

Srikanth Seethala

Advanced Heart Failure and Transplant Cardiology · Boise, ID

NPI 1982803292

$96,462.34

in general payments reported to CMS, 2019-2025

26 companies · $28K in 2025

The $28K reported for 2025 was more than what 87% of Advanced Heart Failure and Transplant Cardiology providers received nationally (typical 2025 total: $1,046).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$74,256.00
Travel and Lodging$12,127.73
Food and Beverage$5,402.64
Education$9.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
E.R. Squibb & Sons, L.L.C. $89,332.23 2019-2025 Camzyos, Eliquis
Abbott Laboratories $2,793.79 2019-2025 Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Mitraclip
Medtronic Vascular, INC. $1,216.98 2019-2020
Abiomed $1,002.00 2020-2025
Actelion Pharmaceuticals US, INC. $335.39 2019-2025 Uptravi, Opsumit, Opsynvi
Novartis Pharmaceuticals Corporation $256.08 2019-2025
Medtronic, INC. $209.01 2022-2023 Reveal Linq
Astrazeneca Pharmaceuticals Lp $193.34 2019-2024 Wainua
United Therapeutics Corporation $188.27 2025 Remodulin, Tyvaso, Remodulin
Atricure, INC. $167.14 2021
Amgen INC. $147.00 2024 Repatha
Bayer Healthcare Pharmaceuticals INC. $128.41 2022-2025
Nuwellis, INC. $97.39 2020
Merck Sharp & Dohme LLC $81.81 2024-2025 Winrevair, Verquvo
One Lambda, INC. $58.65 2022
Show all 24 companies
CompanyGeneral paymentsYearsTop products
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $55.74 2021-2023 Lifevest
Boehringer Ingelheim Pharmaceuticals, INC. $47.96 2020-2024 Jardiance
Endotronix, INC. $33.56 2025 Cordella Pulomonary Artery Pressure Sensor
Scpharmaceuticals INC. $27.79 2025
Alnylam Pharmaceuticals INC. $25.07 2025 Amvuttra
Otsuka America Pharmaceutical, INC. $20.05 2019
Pfizer INC. $19.23 2019
Lantheus Medical Imaging, INC. $12.85 2019
Daiichi Sankyo INC. $12.60 2019

2 companies reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Srikanth Seethala

$96,462.34

in general payments reported 2019-2025

Years
2019-2025
Top company
E.R. Squibb & Sons, L.L.C.
Context
The $28K reported for 2025 was more than what 87% of Advanced Heart Failure and Transplant Cardiology providers received nationally (typical 2025 total: $1,046).

https://glasscript.com/doctor/790093/srikanth-seethala

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.